Cancer and cardiovascular disease are the two most common causes of death. The association between cardiotoxicity and cancer treatment has been known for some time. But, cardio-oncology as a medical subspecialty is fairly new. Cancer Registrars should understand the risks, short- and long-term side effects if they are to accurately review and document the patient’s continuum of care. To get you started here is a short 3.5 minute video.
Can cancer patients skip conventional chemotherapy and radiation therapy treatments and undergo T-cell therapy instead? New research conducted by UCLA, Stanford and others shows promise. Watch this video below.
The National Cancer Registrar’s Association (NCRA) will launch its first hybrid conference April 6-9, 2022 in Washington D.C. with the return of the long-awaited in-person conference plus an option to register for virtual sessions. More info on registration and lodging will be announced later this year.
The window to submit oral presentation and poster abstracts is now open. Deadline to submit is August 27, 2021. All submissions are reviewed by the 2022 Program Comimttee and selected presenters will be notified by November 5, 2021. Registrars are encouraged to submit their topics, best practices and Registry solutions using the following links:
Some suggested topics include:
After you have logged into the Abstract Collection Site you will be asked to identify if your topic is for oral presentation or a poster. The 2022 Program Committee makes the final decision on the intended presentation’s format and will ask the presenter(s) for their agreement. Each submission includes a short, descriptive title, three learning objectives, a 150-word description, and a 100-word presenter bio. Oral presentations are being accepted for both plenary (45-60 minutes) and concurrent (30-45 minute) sessions.